Enzo BioChem reduces loses in 1st quarter

Enzo BioChem Inc.,Manhattan

Biochemical research and development

First quarter: Ended Oct. 31

Net income: Loss of $1.1 million, compared with loss of $1.9 million in the same period last year

Revenue: $25.7 million, compared with $25.2 million a year ago

Charges: $1.8 million inventory and severance

Company statement: The company, which has a major division, Enzo Clinical Labs, based in Farmingdale, said, "We are pleased to report that our program instituted this quarter aimed at making Enzo more efficient and designed to produce more effective use of our assets is beginning to show results, as demonstrated by improved performance."